Muna Therapeutics (Copenhagen, Denmark & Leuven, Belgium) pioneers the development of CNS penetrant small molecules aimed to slow down the progression of several neurodegenerative diseases (Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD)). — Munatherapeutics.com
Location: Denmark, Capital Region of Denmark, Copenhagen
Total raised: $73M
Investors 3
| Date | Name | Website |
| - | V-Bio Vent... | v-bio.vent... |
| - | Droia Onco... | droiaventu... |
| 14.02.2022 | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.07.2021 | Series A | $73M | - |
Mentions in press and media 5
| Date | Title | Description |
| 26.07.2024 | Leading innovation: 10 promising European startups focusing on biopharmaceuticals | Biopharmaceuticals, often known as bio-pharma, represent a dynamic sector within the pharmaceutical industry that uses biological processes to develop drugs and therapies. Unlike traditional pharmaceuticals, which are typically synthesized ... |
| 13.07.2021 | Digital health news, funding roundup week of July 12 | Osso VR secured $27M, Linus Health landed $55M; Thrive Global raised $80M RealSleep: RealSleep is a L.A.-based company making what it says is a fully customizable, cannabinoid-based sleep aid. RealSleep has raised $2.2 million in seed fundi... |
| 12.07.2021 | In Didi’s crackdown, the battle for new oil is on | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The founders of China’s largest ride-sharing operation had less than a week to revel in their new... |
| 09.07.2021 | Muna Therapeutics Raises US$73M in Series A Funding | Muna Therapeutics, a Copenhagen, Denmark-based biopharmaceutical company, raised US$73M in Series A funding. The round was led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund with participation from Polaris Partne... |
| 09.07.2021 | Novo Holdings Launches Muna Therapeutics With US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases | Novo Holdings created and built Muna Therapeutics with pioneers in the field of neurodegeneration Led by an experienced management team of Entrepreneurs-in-Residence from Novo Seeds Financing co-led by Novo Holdings, Sofinnova Partners, Dro... |